GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues

STIMULATION 0301 basic medicine Cannabinoid receptor Supplementary Data ENDOCANNABINOID LEVELS Skeletal muscle Biochemistry ACTIVATION Mice Insulin Phosphorylation Receptors, Cannabinoid Adiposity Mice, Knockout /dk/atira/pure/subjectarea/asjc/1300/1303 Adipogenesis R name=Biochemistry MUSCLE 3. Good health Adipose Tissue Liver OBESITY POTENTIAL ROLE Biotechnology /dk/atira/pure/subjectarea/asjc/1300/1305 Signal Transduction 570 /dk/atira/pure/subjectarea/asjc/1300/1311 /dk/atira/pure/subjectarea/asjc/1300/1312 name=Genetics 610 612 R Medicine liver adipogenesis 03 medical and health sciences SDG 3 - Good Health and Well-being 3T3-L1 Cells Cell Line, Tumor Genetics Animals Humans skeletal muscle Muscle, Skeletal Molecular Biology Endocannabinoid CARDIOMETABOLIC RISK-FACTORS IDENTIFICATION GLUCOSE-UPTAKE Research cannabinoid receptor name=Biotechnology endocannabinoid name=Molecular Biology Rats CANNABINOID RECEPTOR GPR55 Biotechnology and Biological Sciences Research Council (BBSRC) Energy Metabolism Proto-Oncogene Proteins c-akt
DOI: 10.1096/fj.201800171r Publication Date: 2018-08-27T17:40:31Z
ABSTRACT
ABSTRACT Emerging evidence indicates that G‐protein coupled receptor 55 (GPR55), a nonclassic of the endocannabinoid system is activated by L‐α‐lysophosphatidylinositol and various cannabinoid ligands, may regulate endocrine function energy metabolism. We examined how GPR55 deficiency modulation affects insulin signaling in skeletal muscle, adipose tissue, liver alongside expression analysis proteins implicated action show GPR55‐null mice display decreased sensitivity these tissues, as evidenced reduced phosphorylation PKB/Akt its downstream targets, concomitant with increased adiposity physical activity relative to wild‐type counterparts. Impaired tissue coincided substrate‐1 abundance whereas epididymal fat it was associated 3‐phosphoinoistide lipid phosphatase, phosphatase tensin homolog. In contrast, activation enhanced cultured muscle cells, adipocytes, hepatocytes; this response negated antagonists gene silencing L6 myotubes. Sustained antagonism 3T3‐L1 adipocytes lipogenesis promoted triglyceride accumulation. Our findings identify positive regulator adipogenesis potential therapeutic target for countering obesity‐induced metabolic dysfunction resistance.—Lipina, C., Walsh, S. K., Mitchell, E., Speakman, J. R., Wainwright, C. L., Hundal, H. impaired peripheral tissues. FASEB 33, 1299–1312 (2019). www.fasebj.org
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (53)
CITATIONS (53)